Addendum: Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report

Detalles Bibliográficos
Autores principales: Rao, Mayank, Bhattacharjee, Meenakshi, Shepard, Scott, Hsu, Sigmund
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2023
Materias:
Addendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171364/
https://www.ncbi.nlm.nih.gov/pubmed/37163235
http://dx.doi.org/10.18632/oncotarget.28428
_version_ 1785039407593553920
author Rao, Mayank
Bhattacharjee, Meenakshi
Shepard, Scott
Hsu, Sigmund
author_facet Rao, Mayank
Bhattacharjee, Meenakshi
Shepard, Scott
Hsu, Sigmund
author_sort Rao, Mayank
collection PubMed
description
format Online
Article
Text
id pubmed-10171364
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-101713642023-05-11 Addendum: Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report Rao, Mayank Bhattacharjee, Meenakshi Shepard, Scott Hsu, Sigmund Oncotarget Addendum Impact Journals LLC 2023-05-10 /pmc/articles/PMC10171364/ /pubmed/37163235 http://dx.doi.org/10.18632/oncotarget.28428 Text en Copyright: © 2023 Rao et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Addendum
Rao, Mayank
Bhattacharjee, Meenakshi
Shepard, Scott
Hsu, Sigmund
Addendum: Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report
title Addendum: Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report
title_full Addendum: Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report
title_fullStr Addendum: Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report
title_full_unstemmed Addendum: Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report
title_short Addendum: Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report
title_sort addendum: newly diagnosed papillary craniopharyngioma with braf v600e mutation treated with single-agent selective braf inhibitor dabrafenib: a case report
topic Addendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171364/
https://www.ncbi.nlm.nih.gov/pubmed/37163235
http://dx.doi.org/10.18632/oncotarget.28428
work_keys_str_mv AT raomayank addendumnewlydiagnosedpapillarycraniopharyngiomawithbrafv600emutationtreatedwithsingleagentselectivebrafinhibitordabrafenibacasereport
AT bhattacharjeemeenakshi addendumnewlydiagnosedpapillarycraniopharyngiomawithbrafv600emutationtreatedwithsingleagentselectivebrafinhibitordabrafenibacasereport
AT shepardscott addendumnewlydiagnosedpapillarycraniopharyngiomawithbrafv600emutationtreatedwithsingleagentselectivebrafinhibitordabrafenibacasereport
AT hsusigmund addendumnewlydiagnosedpapillarycraniopharyngiomawithbrafv600emutationtreatedwithsingleagentselectivebrafinhibitordabrafenibacasereport

Ejemplares similares